Companies /Healthcare

Standard BioTools Inc

NASDAQ: LAB Medical Devices
$0.65
â–² $0.00 (+0.18%) today
Markets closed · 4:49pm ET
Today · % change

Fundamentals

Market Cap
$255.2M
Profit Margin
100.4%
Revenue (TTM)
$84.6M
EPS (TTM)
$-0.13
52-Week Range
$1 – $2
Street Target
$1.35

About Standard BioTools

Standard BioTools Inc. is a global provider of innovative tools for the life sciences sector, focusing on research and clinical laboratories. The company designs and sells a broad range of products including analytical systems like Helios and Hyperion, assays, reagents, and software solutions aimed at advancing immuno-oncology, genotyping, and single-cell microfluidics. With a strong emphasis on technology and collaboration, Standard BioTools partners with leading institutions and companies to enhance scientific discovery and healthcare. Originally known as Fluidigm Corporation, it rebranded in 2022 and is based in South San Francisco, California.

LAB Coverage